one has to think management couldn’t possibly deliver another Vivagel disaster and by their own admission they are already manufacturing Viraleze in the month of Jan. It travels well, doesn’t require cold storage and apparently the Perth trials aren’t needed to be able to sell in Europe. Shorters are seemingly closing out positions and C19 is at the height of its overwhelming of health care infrastructure. looks like it should beat all other competing nasal sprays to market.
this has to be the slam dunk commercial success that was so cruelly denied us in 2018, even if only for the non US market. Weeks away but surely announcements anytime, how is this not a strong buy??
Almost a year .... turtle company, page-5
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.5¢ |
Change
-0.003(3.06%) |
Mkt cap ! $39.17M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.5¢ | $12.55K | 130.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 586785 | 9.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.7¢ | 56840 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |